Canadian Firm begins training people who will use it’s Keeogo walking assistive device

Stuart SchlossmanAlternative therapies and devices for Multiple Sclerosis (MS)


                                                                  

  


Click here to receive MS news via e-mail


b-temialogo




B-Temia announced the launch of its “b-Klinic Mobility” business unit, offering clinical services, information, training, and ongoing support to patients and healthcare professionals who use the company’s Keeogo walking assistive device.

Keeogo is B-Temia’s first product in the class of dermoskeletons, designed to assist persons with mobility-related challenges that limit their ability to participate in daily activities, such as walking, climbing or descending stairs, sitting down, or standing up.
The device is for use in a variety of degenerative conditions that limit mobility, including multiple sclerosis, knee/hip osteoarthritis, Parkinson’s disease, stroke, and spinal cord injury.
Commercially available for purchase or rental in Canada, Keeogo is under investigation in a multicenter clinical trial (NCT02904382) aimed at obtaining the U.S. Food and Drug Administration (FDA) clearance needed to enter the U.S. market.
Keeogo utilizes sensors at the knee and hip joints to read a person’s body position and desired movement, and to provide the needed assistance to help complete that action. Keeogo does not initiate movement, but waits for the wearer’s lead and first indication, then assists in executing it — like pushing up when the wearer begins to stand up, or slowly supporting a person who is starting to sit down. For more information on how Keeogo works click here.

Read more/See more – here






MS Views and News
Providing educational information, resources and services for those affected by MS


Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews